A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

Tumor heterogeneity, which refers to variations in the cellular and genetic components between cancer cells within a tumor, can complicate the determination of optimal treatment approaches for ...

Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...

Prostate cancer screening plans could be scaled back even further, despite growing calls for more testing to be rolled out.

Recent advances in prostate cancer awareness have transformed how the disease is detected and treated. New screening tools, including AI-enhanced MRI and urine-based biomarker tests, are catching ...

As reports surface that the UK’s national screening committee are set to reject proposals for any national prostate screening programme, experts warn that the decision, if followed through with, puts ...

A prostate cancer screening trial will make recruiting black men a priority because they face double the risk of getting the ...

The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation. The £42m trial is being co-led by UCL, ...

A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

The first men have taken part in a major UK trial testing new ways to screen for prostate cancer and detect the disease earlier ...